Search Results

Integrated continuous manufacturing of inhalable remdesivir nanoagglomerate dry powders: Design, optimization and therapeutic potential for respiratory viral infections.

• Authors : Chan HW; Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.; Lee HW

Subjects: Virus Diseases*; Humans ; Powders

• Source: International journal of pharmaceutics [Int J Pharm] 2023 Sep 25; Vol. 644, pp. 123303. Date of Electronic Publication: 2023 Aug 12.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium:

Record details

Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease.

• Authors : Cross RW; Galveston National Laboratory and.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.

Subjects: Ebolavirus* ; Hemorrhagic Fever, Ebola*/Hemorrhagic Fever, Ebola*/Hemorrhagic Fever, Ebola*/drug therapy ; Hemorrhagic Fever, Ebola*/Hemorrhagic Fever, Ebola*/Hemorrhagic Fever, Ebola*/prevention & control

• Source: JCI insight [JCI Insight] 2022 May 23; Vol. 7 (10). Date of Electronic Publication: 2022 May 23.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium:

Record details

Applied Science & Technology Full Text (H.W. Wilson)

Record details

Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection.

• Authors : Saha, Tushar; Sinha, Shubhra; Harfoot, Rhodri

Subjects: CORONAVIRUS disease treatment; COVID-19; REMDESIVIR

• Source: Pharmaceutics; Sep2023, Vol. 15 Issue 9, p2229, 12p

Record details

Long-term persistence of mitochondrial dysfunctions after viral infections and antiviral therapies: A review of mechanisms involved.

• Authors : Gay L; Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, Etablissement Français du Sang, University of Antilles, Montpellier, France.; Desquiret-Dumas V

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Mitochondria*/Mitochondria*/Mitochondria*/drug effects ; DNA, Mitochondrial*/DNA, Mitochondrial*/DNA, Mitochondrial*/genetics

• Source: Journal of medical virology [J Med Virol] 2024 Sep; Vol. 96 (9), pp. e29886.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071

Record details

Calibration and Validation of a Mechanistic COVID‐19 Model for Translational Quantitative Systems Pharmacology – A Proof‐of‐Concept Model Development for Remdesivir.

• Authors : Samieegohar, Mohammadreza; Weaver, James L.; Howard, Kristina E.

Subjects: COVID-19; COVID-19 pandemic; PHARMACOLOGY

• Source: Clinical Pharmacology & Therapeutics; Oct2022, Vol. 112 Issue 4, p882-891, 10p

Record details

Case report: Clearance of longstanding, immunedeficiency-associated, vaccinederived polio virus infection following remdesivir therapy for chronic SARS-CoV-2 infection.

• Authors : Bermingham, William Hywel; Canning, Benjamin; Wilton, Thomas

Subjects: POLIO; SARS-CoV-2; VIRUS diseases

• Source: Frontiers in Immunology; 3/3/2023, Vol. 14, p1-6, 6p

Record details

Drug Nanocrystals: A Delivery Channel for Antiviral Therapies.

• Authors : Chaturvedi A; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER) - Raebareli, Lucknow, 226002, India.; Sharma S

Subjects: Virus Diseases*/Virus Diseases*/Virus Diseases*/drug therapy ; Nanoparticles*/Nanoparticles*/Nanoparticles*/chemistry; Humans

• Source: AAPS PharmSciTech [AAPS PharmSciTech] 2024 Feb 17; Vol. 25 (3), pp. 41. Date of Electronic Publication: 2024 Feb 17.Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932

Record details

Paving new roads toward the advancement of broad-spectrum antiviral agents.

• Authors : Du R; Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.; Qingdao Academy of Chinese Medical Sciences, Shandong University of Traditional Chinese Medicine, Qingdao, China.

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; Virus Diseases*/Virus Diseases*/Virus Diseases*/drug therapy; Animals

• Source: Journal of medical virology [J Med Virol] 2024 Jan; Vol. 96 (1), pp. e29369.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071

Record details

RedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola.

• Source: PR Newswire. 2023.

Record details